Tenet Healthcare Co. (NYSE:THC – Free Report) – Stock analysts at Zacks Research reduced their Q1 2026 earnings estimates for Tenet Healthcare in a research report issued on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3.43 per share for the quarter, down from their prior forecast of $3.45. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $3.56 EPS and FY2026 earnings at $13.40 EPS.
A number of other research firms have also recently weighed in on THC. StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. Barclays decreased their target price on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a research report on Thursday, February 13th. KeyCorp cut their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Morgan Stanley initiated coverage on shares of Tenet Healthcare in a research report on Wednesday. They issued an “overweight” rating and a $165.00 target price on the stock. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 13th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $166.41.
Tenet Healthcare Trading Down 0.9 %
Shares of Tenet Healthcare stock opened at $133.17 on Friday. Tenet Healthcare has a fifty-two week low of $90.03 and a fifty-two week high of $171.20. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The company has a market cap of $12.67 billion, a P/E ratio of 4.13, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06. The firm has a 50-day simple moving average of $132.43 and a two-hundred day simple moving average of $142.50.
Tenet Healthcare (NYSE:THC – Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.
Institutional Trading of Tenet Healthcare
Hedge funds have recently made changes to their positions in the business. New Wave Wealth Advisors LLC purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $343,000. Swedbank AB grew its stake in Tenet Healthcare by 100.0% during the 4th quarter. Swedbank AB now owns 40,000 shares of the company’s stock worth $5,049,000 after purchasing an additional 20,000 shares in the last quarter. Signet Financial Management LLC acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $1,526,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in Tenet Healthcare in the fourth quarter worth approximately $5,892,000. Institutional investors and hedge funds own 95.44% of the company’s stock.
Insider Buying and Selling
In related news, Director J Robert Kerrey sold 9,525 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.93% of the stock is currently owned by company insiders.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also
- Five stocks we like better than Tenet Healthcare
- Learn Technical Analysis Skills to Master the Stock Market
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Expert Stock Trading Psychology Tips
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- 3 Best Fintech Stocks for a Portfolio Boost
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.